Abstract:Immunotherapeutic strategies for disinhibiting T cell responses have revolutionized lung cancer treatment. However, the identification of tumor-reactive T cells and the acquisition of adequate tissue for molecular and immune profiling remains a challenge that hinders our ability to adequately characterize the mechanisms of immunotherapy response versus resistance. To address this gap, we are investigating the use of bronchoalveolar lavage (BAL) as an alternative to blood or tumor biopsy samples to identify tumor reactive T cells. We collected cells from a prospective bronchoscopic biorepository of patients undergoing lung cancer evaluation that were subjected to bilateral BAL, phlebotomy, and tissue sampling. We then employed flow cytometry and single-cell multi-omic analyses to identify, characterize and clonotypically track tumor-reactive T cells obtained from BAL, blood and tumor samples from lung cancer patients. Analysis of BAL samples revealed a significant enrichment of terminally exhausted CD8+CD39+CD103+ T cells in BAL from tumor-bearing lungs compared to non-tumor bearing lung BAL and blood PBMCs in 14 patients. We then used single-cell sequencing-based multi-omics to deeply profile bilateral BAL cells, blood PBMCs and tumor tissues from 5 of these patients. By tracking T cell receptor (TCR) sequences across patient-matched samples, we found BAL derived T cell clonotypes that expressed markers of terminal exhaustion, such as CD39 and CXCL13 in the tumor, which strongly implicates them as being tumor reactive and relatively abundant in BAL. Further validation through functional assays is being used to confirm the tumor reactivity of these clones. These data demonstrate the feasibility of capturing tumor-specific T cells during bronchoscopy, providing promising opportunities for patient outcome characterization and exploration of novel therapies. This relatively non-invasive and practical test during routine bronchoscopy offers a cost-effective and safe alternative to identifying tumor-reactive T cells from surgical specimens or biopsies. Citation Format: Heeju Ryu, Wei Sun, Michelle A. Wurscher, Viswam S. Nair, Evan W. Newell. Identification, profiling and clonotypic tracking of tumor-reactive T cells derived from bronchoalveolar lavage in lung cancer patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 3862.

Alloreactivity of lung biopsy and bronchoalveolar lavage‐derived lymphocytes from pulmonary transplant patients: Correlation with acute rejection and bronchiolitis obliterans

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Insights from T Cell Profiling in BAL and PBMC

Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies

Transbronchial Lung Biopsy in Diagnosis of Acute Rejection after the Lung Transplantation

Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection

Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients

Alloreactive T lymphocytes cultured from liver transplant biopsies: Associations of HLA specificity with clinicopathological findings

Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients

Lymphocytic Airway Inflammation in Lung Allografts

Alloreactive T Cells Temporarily Increased in Peripheral Blood of Patients Before Liver Allograft Rejection

LTB4 and Montelukast in Transplantation-Related Bronchiolitis Obliterans in Rats

[Lung transplantation : Histomorphological diagnosis and clinical aspects]

Abstract 3862: Identification, profiling and clonotypic tracking of tumor-reactive T cells derived from bronchoalveolar lavage in lung cancer patients

Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients

Transition from Transbronchial Forceps to Cryobiopsy After Lung Transplantation: A Single-Centre Experience

Transbronchial Cryobiopsy Versus Transbronchial Forceps Biopsy for Acute Cellular Rejection Detection in Lung Transplantation: A Meta-Analysis

Allostimulation leads to emergence of a human B cell population with increased expression of HLA class I antigen presentation-associated molecules and the immunoglobulin receptor FcRL5

Donor Derived Exosomes Expressing Lung Associated Self-antigens (collagen V and K Alpha 1 Tubulin) in Acute and Chronic Rejection Following Human Lung Transplantation

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer